Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia - Biogen
  Biogen Inc. (NASDAQ:BIIB) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
  21GRAMS Wins Its First Gold Lion for Branded Pharma Campaign at Cannes Lions International Festival of Creativity - Business Wire
  Pharma roars onto the Cannes Pharma Lions podium, with Viatris winning Grand Prix and Biogen taking home Gold - Fierce Pharma
  Having rebuffed Biogen, Sage settles on takeout by Supernus - FirstWord Pharma
  H.C. Wainwright sees potential competition for Sage from Biogen - Yahoo Finance
  Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics - Fierce Biotech
  Biogen and City Therapeutics Announce Strategic Research - GlobeNewswire